Korean Market
EXCH
Sinsin Pharmaceutical
★★★

Early Termination and Withdrawal of Phase 3 Clinical Trial for Overactive Bladder Drug UIP620

 
EXCH
Sinsin Pharmaceutical
★★

SS262 Insomnia Treatment Phase 1 Trial Terminated Early, Shift to New Pipeline Development

 
PERI
Sinsin Pharmaceutical
★★★

Sinsin Pharma Q1 2026: Sales +19%, Net Profit +185%

 
EXCH
Sinsin Pharmaceutical
★★

Shinshin Pharm Section Change to Blue-Chip (2026-05-04)